Journal Browser

Go Edit a Special Issue

Archive

Special Issue Title:

Advances in Obstetric Anaesthesia

Deadline for manuscript submissions: 31 May 2023

Print Special Issue Flyer (6)

Special Issue Editor

  • Guest Editor

    Prof. Tatjana Stopar Pintarič, MD, PhD, DEAAE-MailWebsite

    Consultant anaesthesiologist, Head of research and development unit, Head of obstetric anaesthesia unit, Clinical department of anaesthesiology and intensive therapy, University Medical Centre Ljubljana, Slovenia; Institute of Anatomy, Medical Faculty Ljubljana, Slovenia

    Interests: Obstetric Anaesthesia; Difficult Airway; Regional Anaesthesia; Applied Anatomy

Special Issue Information

Advances in obstetric anaesthesia over the last decade have spanned multiple areas. Enhancement in neuraxial labour analgesic techniques, postpartum pain management modalities and prevention of intraoperative hypotension during caesarean delivery have contributed to the improvement of care. More progress is needed in many areas, including the influence of epidural analgesia on the duration of the second stage of labour and instrumental vaginal delivery rates, the safety of remifentanil-PCA for labour analgesia and its influence on labour and delivery outcomes, the establishment of enhanced recovery protocols after labour or caesarean delivery, the implementation of key indicators to drive quality improvements in perinatal care and obstetric anaesthesia, the use of point of care coagulation testing for managing obstetric haemorrhage, the implementation of novel analgesic techniques for managing the post-punction headache etc. 


The goal of this special issue is to collect as many contributions as possible on these topics relevant to obstetric anaesthesia to help clinicians to improve and personalize obstetric anaesthesia therapies and interventions. With a view to this goal, we are cordially inviting all the members of the obstetrical team, anaesthesiologists, perinatologists, neonatologists and midwifes to contribute to this special issue. 

Keywords

Obstetric Anaesthesia; Epidural Analgesia; Remifentanil-PCA; Labour and Delivery Outcomes; Quality Control in Perinatology and Obstetric Anaesthesia; ROTEM; Obstetric Haemorrhage; Preeclampsia

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences